TY - JOUR
T1 - Management of Esophago-Gastric Junction Carcinoma: A Narrative Multidisciplinary Review
AU - Tondolo, Vincenzo
AU - Casà, Calogero
AU - Rizzo, Gianluca
AU - Leone, Mariavittoria
AU - Quero, Giuseppe
AU - Alfieri, Virginia
AU - Boldrini, Luca
AU - Bulajic, Milutin
AU - Corsi, Domenico Cristiano
AU - Micciché, Francesco
PY - 2023
Y1 - 2023
N2 - The management of esophagogastric junction (EGJ) cancer is multidisciplinary, and due to its specificity, requires a high-volume center with high medical and surgical expertise. The aim of this narrative review was to critically analyze the evidence and guidelines in the literature and examine the tips and tricks in surgical and medical treatment to increase the long-term outcome of patients with this kind of tumor.Esophagogastric junction (EGJ) carcinoma represents a specific site of disease, given the opportunities for multimodal clinical care and management and the possibilities of combined treatments. It encompasses various clinical subgroups of disease that are heterogeneous and deserve different treatments; therefore, the guidelines have progressively evolved over time, considering the evidence provided by clinical trials. The aim of this narrative review was to summarize the main evidence, which orientates the current guidelines, and to collect the main ongoing studies to address existing gray areas.
AB - The management of esophagogastric junction (EGJ) cancer is multidisciplinary, and due to its specificity, requires a high-volume center with high medical and surgical expertise. The aim of this narrative review was to critically analyze the evidence and guidelines in the literature and examine the tips and tricks in surgical and medical treatment to increase the long-term outcome of patients with this kind of tumor.Esophagogastric junction (EGJ) carcinoma represents a specific site of disease, given the opportunities for multimodal clinical care and management and the possibilities of combined treatments. It encompasses various clinical subgroups of disease that are heterogeneous and deserve different treatments; therefore, the guidelines have progressively evolved over time, considering the evidence provided by clinical trials. The aim of this narrative review was to summarize the main evidence, which orientates the current guidelines, and to collect the main ongoing studies to address existing gray areas.
KW - esophago-gastric junction carcinoma
KW - mini-invasive surgery
KW - multidisciplinary approach
KW - preoperative chemoradiotherapy
KW - tailored treatment
KW - esophago-gastric junction carcinoma
KW - mini-invasive surgery
KW - multidisciplinary approach
KW - preoperative chemoradiotherapy
KW - tailored treatment
UR - http://hdl.handle.net/10807/280139
U2 - 10.3390/cancers15092597
DO - 10.3390/cancers15092597
M3 - Meeting Abstract
SN - 2072-6694
VL - 15
SP - 1
EP - 16
JO - Cancers
JF - Cancers
ER -
